Skip to content

The 3-Dimensional Ultrasound for Fetal Anomaly Scan

The 3-Dimensional Ultrasound for Fetal Anomaly Scan.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00966537
Enrollment
600
Registered
2009-08-27
Start date
2008-05-31
Completion date
Unknown
Last updated
2009-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

to study the clinical application of 3D/4D ultrasound for fetal scanning, to study the clinical application of 3D/4D ultrasound for pelvic scanning;, to demonstrate how to optimally display the different organs., to correlate our findings with other diagnostic tools like MRI, CT;, to correlate our findings with clinical outcome.

Brief summary

The aim of this study is 1) to study the clinical application of 3D/4D ultrasound for fetal scanning during pregnancy; 2) ) to study the clinical application of 3D/4D ultrasound for pelvic scanning; 3) to demonstrate how to optimally display the different organs. 4) to correlate our findings with other diagnostic tools like MRI, CT; 5) to correlate our findings with clinical outcome.

Detailed description

A prospective studies of patients that coming to the ultrasound (US) unit in Sheba Medical Center from November 2007 for diagnostic US examination. Patients will receive information of the study (printed and oral) and will ask to sign informed consent to act as a research subject and permission to use personal heath information for research. Studies is performed using commercially available ultrasound equipment (Voluson 730 Expert, General Electric Healthcare, Kretztechnik, Zipf, Austria) with volumetric abdominal RAB 4-8 MHz and volumetric transvaginal RIC 5-9 MHz transducer probes. During the examination of the patient pictures and 3D/4D volumes will acquired either by static 3D or 4D Volume or STIC (Spacio Temporal Image Corelation), Contrast Imaging in plane C (VCI-C) with and without Doppler (Color, Power and High Definition) and with B-flow. Image quality will be assessed in various modes. For optimizing the image volumes manipulations will be performed by positioning of the

Interventions

None listed

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* pregnant woman who come for fetal anomaly scan.

Exclusion criteria

\-

Countries

Israel

Contacts

Primary ContactLiat Gindes, MD
gindesl@smile.net.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026